ArticleActa obstetricia et gynecologica Scandinavica2024
First experience with the Hugo™ robot-assisted surgery system for endometriosis: A descriptive study.
Article in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.
- Emerging robotic platforms in gynecologic surgery: a systematic review.Journal of robotic surgery · 2026Pooled it
- The Hugo™ RAS system in gynecologic robotic surgery: a systematic review of current applications.Journal of robotic surgery · 2025Pooled it
- Port placement and patient-specific docking strategies for robotic hysterectomy with the Hugo™ RAS system: an international Delphi consensus.Facts, views & vision in ObGyn · 2026Article
- Optimizing arm placement in the HugoUpdates in surgery · 2025Article
- Bridging the gap: feasibility and future directions of robotic surgery in Sub-Saharan Africa-a narrative review.Journal of robotic surgery · 2025Review
- Bibliometric analysis of global research dynamics in robot-assisted hysterectomy over the past 20 years.Journal of robotic surgery · 2025Review
- Current status of robot-assisted surgery implementation in endometriosis centers: an international multicentric cross-sectional study.Archives of gynecology and obstetrics · 2025Article
- Novel Minimally Invasive Surgical Approaches to Endometriosis and Adenomyosis: A Comprehensive Review.Journal of clinical medicine · 2024Review
- First experience with the Hugo™ robot-assisted surgery system for endometriosis: A descriptive study.Acta obstetricia et gynecologica Scandinavica · 2024Article
- Robotic surgery for deep-infiltrating endometriosis: is it time to take a step forward?Frontiers in medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Medtronic Hugo™ Robot-assisted Surgery (RAS) system was recently approved for clinical use. We explored the safety and feasibility of this system for endometriosis surgery. The primary outcome was safe case completion without major surgical complications (Clavien-Dindo grade ≤2) and no conversion to open surgery or laparoscopy. MATERIAL AND
methodsSurgeries for endometriosis performed at the Department of Gynecology, Rigshospitalet, on the Medtronic Hugo™ RAS system were included. Two experienced robotic surgeons performed all surgeries with their usual robotic team. The variables included were patient demographics, peri- and postoperative data, complications and 30-day readmission rate. We used the IDEAL framework 1/2a for surgical innovation in this descriptive study.
resultsThe first 12 patients were included. All cases were completed without intraoperative complications or conversion. Four patients experienced Clavien-Dindo grade 1 postoperative complications. No patients were re-admitted within 30 days. Median docking time (17 minutes), console time (87.5 minutes), blood loss (40 mL) and length of hospital stay (1 day) were acceptable compared with previous literature.
conclusionsIn this pilot study, we found the Medtronic Hugo™ RAS system safe and feasible for robot-assisted surgery for endometriosis. The advent of new robotic systems is welcomed to accelerate the development of technology that will advance surgical care for patients across the globe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.